Table: Kubota Pharmaceutical Holdings -2016 group results (SEC)
Feb 14 (Reuters)-
Kubota Pharmaceutical Holdings Co., Ltd.
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Dec 31, 2016 Dec 31, 2015 Dec 31, 2017 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULT FORECAST H1 FORECAST
Sales 870 mln 0 mln
Operating loss 4.12 loss 4.29
Pretax loss 3.95 loss 4.18
Net loss 3.95 loss 4.18
EPS loss 105.64 yen loss 110.00 yen
Ann Div NIL NIL NIL
-Q2 Div NIL NIL NIL
-Q4 Div NIL NIL NIL
NOTE - Kubota Pharmaceutical Holdings Co., Ltd..
(Figures are reported based on U.S. accounting rules set by the U.S. Securities
and Exchange Commission.)
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4596.T
((Tokyo Headline News Desk +813 6441 1812))
Recent news on Kubota Pharmaceutical Holdings
See all newsTable: Kubota Pharmaceutical Holdings 6-MTH group results (IFRS)
Table: Kubota Pharmaceutical Holdings -Q1 group results (IFRS)
Brief: Kubota Vision Signs Supply & Licensing Agreement With Laboratoires Kôl
Table: Kubota Pharmaceutical Holdings -2025 parent results
Table: Kubota Pharmaceutical Holdings -2025 group results (IFRS)